Once-daily tiotropium Respimat (R) as add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status

R. Dahl; E. D. Bateman; T. Casale; E. Pizzichini; M. Vandewalker; J. C. Virchow; M. Engel; R. Sigmund; P. Moroni-Zentgraf; H. A. M. Kerstjens

Once-daily tiotropium Respimat (R) as add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status

R. Dahl, E. D. Bateman, T. Casale, E. Pizzichini, M. Vandewalker, J. C. Virchow, M. Engel, R. Sigmund, P. Moroni-Zentgraf, H. A. M. Kerstjens

Groningen Research Institute for Asthma and COPD (GRIAC)

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	515-515
Number of pages	1
Journal	Allergy
Volume	69
Publication status	Published - Sept-2014
Event	European-Academy-of-Allergy-and-Clinical-Immunology Congress - Copenhagen, Copenhagen, Denmark Duration: 7-Jun-2014 → 11-Jun-2014

Access to Document

http://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=5&SID=P1Fyq7czRMOiHE9ZbQ2&page=1&doc=1

Handle.net

Persistent link

Cite this

Dahl, R., Bateman, E. D., Casale, T., Pizzichini, E., Vandewalker, M., Virchow, J. C., Engel, M., Sigmund, R., Moroni-Zentgraf, P., & Kerstjens, H. A. M. (2014). Once-daily tiotropium Respimat (R) as add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status. Allergy, 69, 515-515. http://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=5&SID=P1Fyq7czRMOiHE9ZbQ2&page=1&doc=1

@article{533f790b426f41038fef26a30ddd7668,

title = "Once-daily tiotropium Respimat (R) as add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status",

author = "R. Dahl and Bateman, {E. D.} and T. Casale and E. Pizzichini and M. Vandewalker and Virchow, {J. C.} and M. Engel and R. Sigmund and P. Moroni-Zentgraf and Kerstjens, {H. A. M.}",

year = "2014",

month = sep,

language = "English",

volume = "69",

pages = "515--515",

journal = "Allergy",

issn = "0105-4538",

publisher = "Wiley-Blackwell",

note = "European-Academy-of-Allergy-and-Clinical-Immunology Congress ; Conference date: 07-06-2014 Through 11-06-2014",

}

Dahl, R, Bateman, ED, Casale, T, Pizzichini, E, Vandewalker, M, Virchow, JC, Engel, M, Sigmund, R, Moroni-Zentgraf, P & Kerstjens, HAM 2014, 'Once-daily tiotropium Respimat (R) as add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status', Allergy, vol. 69, pp. 515-515. <http://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=5&SID=P1Fyq7czRMOiHE9ZbQ2&page=1&doc=1>

TY - JOUR

T1 - Once-daily tiotropium Respimat (R) as add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status

AU - Dahl, R.

AU - Bateman, E. D.

AU - Casale, T.

AU - Pizzichini, E.

AU - Vandewalker, M.

AU - Virchow, J. C.

AU - Engel, M.

AU - Sigmund, R.

AU - Moroni-Zentgraf, P.

AU - Kerstjens, H. A. M.

PY - 2014/9

Y1 - 2014/9

M3 - Meeting Abstract

SN - 0105-4538

VL - 69

SP - 515

EP - 515

JO - Allergy

JF - Allergy

T2 - European-Academy-of-Allergy-and-Clinical-Immunology Congress

Y2 - 7 June 2014 through 11 June 2014

ER -